Steven Cohen's BMRN Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 438,817 shares of BioMarin Pharmaceutical Inc. (BMRN) worth $26.08 M, representing 0.03% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 36 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in BMRN, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2020, adding 943,693 shares. Largest reduction occurred in Q2 2024, reducing 1.35 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's BioMarin Pharmaceutical (BMRN) Holding Value Over Time
Track share changes against reported price movement
Quarterly BioMarin Pharmaceutical (BMRN) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +438,817 | New Buy | 438,817 | $59.43 |
| Q2 2025 | -395,750 | Sold Out | 0 | $0.00 |
| Q1 2025 | +129,314 | Add 48.53% | 395,750 | $70.69 |
| Q4 2024 | +68,718 | Add 34.76% | 266,436 | $65.73 |
| Q3 2024 | +197,718 | New Buy | 197,718 | $70.29 |
| Q2 2024 | -1.35 M | Sold Out | 0 | $0.00 |
| Q1 2024 | +890,420 | Add 195.57% | 1.35 M | $87.34 |
| Q4 2023 | +455,300 | New Buy | 455,300 | $96.42 |
| Q1 2023 | -716,700 | Sold Out | 0 | $0.00 |
| Q4 2022 | +121,300 | Add 20.37% | 716,700 | $103.49 |
| Q3 2022 | +447,529 | Add 302.65% | 595,400 | $84.77 |
| Q2 2022 | -218,965 | Reduce 59.69% | 147,871 | $82.87 |
| Q1 2022 | -454,960 | Reduce 55.36% | 366,836 | $77.10 |
| Q4 2021 | +30,007 | Add 3.79% | 821,796 | $88.35 |
| Q3 2021 | +425,289 | Add 116.04% | 791,789 | $77.29 |
| Q2 2021 | +110,000 | Add 42.88% | 366,500 | $83.44 |
| Q1 2021 | -124,600 | Reduce 32.69% | 256,500 | $75.51 |
| Q4 2020 | -562,593 | Reduce 59.62% | 381,100 | $87.69 |
| Q3 2020 | +943,693 | New Buy | 943,693 | $76.08 |
| Q1 2020 | -260,683 | Sold Out | 0 | $0.00 |
| Q4 2019 | +196,010 | Add 303.08% | 260,683 | $84.55 |
| Q3 2019 | -186,973 | Reduce 74.30% | 64,673 | $67.40 |
| Q2 2019 | +251,646 | New Buy | 251,646 | $85.65 |
| Q3 2018 | -53,703 | Sold Out | 0 | $0.00 |
| Q2 2018 | -198,397 | Reduce 78.70% | 53,703 | $94.20 |
| Q1 2018 | -245,249 | Reduce 49.31% | 252,100 | $81.07 |
| Q4 2017 | -272,193 | Reduce 35.37% | 497,349 | $89.17 |
| Q3 2017 | +769,542 | New Buy | 769,542 | $93.07 |
| Q2 2017 | -364,800 | Sold Out | 0 | $0.00 |
| Q1 2017 | -161,800 | Reduce 30.73% | 364,800 | $87.78 |
| Q4 2016 | +372,900 | Add 242.62% | 526,600 | $82.84 |
| Q3 2016 | +153,700 | New Buy | 153,700 | $92.52 |
| Q1 2015 | -74,600 | Sold Out | 0 | $0.00 |
| Q4 2014 | -601,000 | Reduce 88.96% | 74,600 | $90.40 |
| Q3 2014 | +585,500 | Add 649.83% | 675,600 | $72.16 |
| Q2 2014 | +90,100 | Add 0.00% | 90,100 | $62.21 |
Steven Cohen's BioMarin Pharmaceutical Investment FAQs
Steven Cohen first purchased BioMarin Pharmaceutical Inc. (BMRN) in Q2 2014, acquiring 90,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held BioMarin Pharmaceutical Inc. (BMRN) for 36 quarters since Q2 2014.
Steven Cohen's largest addition to BioMarin Pharmaceutical Inc. (BMRN) was in Q3 2020, adding 943,693 shares worth $71.8 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 438,817 shares of BioMarin Pharmaceutical Inc. (BMRN), valued at approximately $26.08 M.
As of the Q4 2025 filing, BioMarin Pharmaceutical Inc. (BMRN) represents approximately 0.03% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in BioMarin Pharmaceutical Inc. (BMRN) was 1,345,720 shares, as reported at the end of Q1 2024.